Interaction of the Anti-Proliferative GPER Inverse Agonist ER?17p with the Breast Cancer Cell Plasma Membrane: From Biophysics to Biology.

ABSTRACT: The peptide ER?17p, which corresponds to the 295-311 fragment of the hinge/AF2 domains of the human estrogen receptor ? (ER?), exerts apoptosis in breast cancer cells through a mechanism involving the G protein-coupled estrogen-dependent receptor GPER. Besides this receptor-mediated mechanism, we have detected a direct interaction (Kd value in the micromolar range) of this peptide with lipid vesicles mimicking the plasma membrane of eukaryotes. The reversible and not reversible pools of interacting peptide may correspond to soluble and aggregated membrane-interacting peptide populations, respectively. By using circular dichroism (CD) spectroscopy, we have shown that the interaction of the peptide with this membrane model was associated with its folding into ? sheet. A slight leakage of the 5(6)-fluorescein was also observed, indicating lipid bilayer permeability. When the peptide was incubated with living breast cancer cells at the active concentration of 10 ?M, aggregates were detected at the plasma membrane under the form of spheres. This insoluble pool of peptide, which seems to result from a fibrillation process, is internalized in micrometric vacuoles under the form of fibrils, without evidence of cytotoxicity, at least at the microscopic level. This study provides new information on the interaction of ER?17p with breast cancer cell membranes as well as on its mechanism of action, with respect to direct membrane effects.

SUBMITTER: Trichet M 

PROVIDER: S-EPMC7072814 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature